Perspectives Patient Education Randomized Study

Not Applicable

Completed

• Conditions: Medication Adherence
• Interventions: Device: MyIDEA

• Registration Number: NCT04439864
• Lead Sponsor: University of Illinois at Chicago

Brief Summary

This is a randomized clinical trial evaluating the educational program called My Interventional Drug Eluting Stent Educational App (MyIDEA) that is a pilot at two sites.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-05-01
• Primary Completion: 2017-02-28
• Study Completion: 2017-02-28
• Status Verified: 2020-06
• Study First Submitted: 2020-06-11
• Study First Submitted QC: 2020-06-17
• Last Update Submitted: 2020-06-17
• Study First Posted: 2020-06-19
• Last Update Posted: 2020-06-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

1. received a drug eluting stent during a Percutaneous Coronary Intervention (PCI) during a hospitalization for the PCI procedure,
2. were greater than 50 years old (funding agency requirement),
3. spoke and understood English.

Exclusion Criteria

1. inability to give informed consent
2. allergy to aspirin

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
MyIDEA	MyIDEA	Research Participants interacted with MyIDEA program both in the hospital and in the follow up cardiology appointment.

Primary Outcome Measures

Name	Time	Method
Feasibility of study design engaging elderly patients in novel tablet based education.	3 months	Would research participants enroll and follow up in a study of tablet based education. Do patients think they know everything? Would patients enrolled in the control arm still follow up in the study?

Secondary Outcome Measures

Name	Time	Method
Medication adherence	3 months	A measure of Pharmacy days covered for DAPT medication. The patients after recieving a Drug Eluting Stent need to adhere to Dual Antiplatlet Therapy (DAPT) to prevent restenosis of the stent. PDC is a calculation of the DAPT which is Aspirin and an ADP receptor antagonist. As aspirin is over the counter, the pharmacy does not have a record of purchase so the PDC was calculated for the ADP receptor antagonis.